Russian producer of nanocontainers, nanotubes and decontaminating chemicals is looking for distributors
The Russian company from Moscow was founded in 2010 and specializes in molecular nanotechnologies and new materials development.
The company is offering 2 types of products:
1. Aluminosilicate nanocontainers, nanotubes, halloysite, adsorbents, catalysts, carriers of biologically active substances, fillers made of functional and structural polymer composite materials, heat-insulating materials, paint and varnish coatings, adhesives, adhesives, sealants.
2. The nanoscale antiseptic, antimycotic, antiparasitic and bactericidal materials of a broad spectrum of activity based on aluminosilicate nanocontainers. Medical products are used in oral and maxillofacial surgery, surgical and therapeutic dentistry and periodontology, for the prevention of wound suppuration and the treatment of purulent (infected) wounds of various origins.
The company is looking for partners operating in the following industries/sectors: healthcare, chemical, nanomaterials (e.g., adsorbents and catalysts), nanopharmaceutics, agriculture, cosmetics, construction materials.
Under the distribution services agreement, the company will supply the product to a reliable distributor with established sales in the forementioned markets for the subsequent sale. Under the manufacturing agreement the company will deliver stipulated consignments of the products to a partner for direct use. In both cases the company will provide product specifications as well as reference and technical documentation.Advantages & innovations Cooperation plus value: 1. The content of halloysite nanotubes is up to 100%.2. Contain as the main phase 10Å-halloysite or 7Å-halloysite, or their arbitrary mixture (at the option of the customer).3. Containers have high uniformity in size and dispersion.4. All the containers and other products as well as manufactured materials and substances are characterized by high purity, chemical composition and homogeneity.5. All products are non-toxic and biocompatible.6. Higher activity of nanoscale substances in comparison with traditional forms.7. Longer (prolonged) biological effect of the active substance.8. Increased stability of sensitive ingredients.9. More steady release and exposure to the active substance.10. Reduced irritating effect of encapsulated substances.11. Stabilization of biologically active ingredients.12. Significantly higher adhesion to tissues; prolonged and uniform therapeutic effects; more local therapeutic effect; simple application technology available for self-administration by patients. Stage of development Cooperation stage dev stage: Already on the market Partner sought Cooperation area: Type: SME's, large companies, MNE's.Role: under the manufacturing agreement, the partner is to pay for a consignment delivered. Under the distribution services agreement, the partner must purchase the product in order to distribute it further. Type and size Cooperation task: SME 11-50,SME 500 MNE,251-500,SME 51-250,>500